Login | Users Online: 215  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
 


 
Table of Contents
HISTORY OF MEDICINE
Year : 2017  |  Volume : 18  |  Issue : 3  |  Page : 109-114  

Risk factors for coronary artery disease: Historical perspectives


Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar

Date of Web Publication8-Nov-2017

Correspondence Address:
M.D. Rachel Hajar
Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha
Qatar
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_106_17

Rights and Permissions

How to cite this article:
Hajar R. Risk factors for coronary artery disease: Historical perspectives. Heart Views 2017;18:109-14

How to cite this URL:
Hajar R. Risk factors for coronary artery disease: Historical perspectives. Heart Views [serial online] 2017 [cited 2022 Sep 26];18:109-14. Available from: https://www.heartviews.org/text.asp?2017/18/3/109/217850


   Introduction Top


We consider our current understanding and therapy of cardiovascular diseases (CVD) state-of-the-art, but heart disease is still a problem because there is still a lot that we do not know. There is still no cure for any form of heart disease. However, research is ongoing, and new clues are emerging which could lead to better treatments in the future. Results from epidemiological studies, foremost among them the Framingham study, have been crucial to our current knowledge about CVD. Emphasis is on the identification of risk factors, assessment of their predictive ability, and their implications for disease prevention.

The concept of “risk factors” in coronary heart disease (CHD) was first coined by the Framingham heart study (FHS), which published its findings in 1957. FHS demonstrated the epidemiologic relations of cigarette smoking, blood pressure, and cholesterol levels to the incidence of coronary artery disease (CAD). The findings were truly revolutionary for it helped bring about a change in the way medicine is practiced.

Beginnings of our understanding

For thousands of years, our knowledge of the causes of CVD and its therapy was static. It was only in the last half of the 20th century that research into the causes of CVDs accelerated, and with it, new therapies were found.

What stimulated this research? The premature death in 1945 of the US President Franklin D. Roosevelt from hypertensive heart disease and stroke stimulated this research in USA.[1] Deaths from CVD and stroke reached epidemic proportions in the USA at that time which induced the Americans to take the lead in cardiovascular research.

The death of President Roosevelt illustrated how little we knew about the general causes of heart disease and stroke. Therefore, a health project was set up in the USA– the FHS – to identify the common factors or characteristics that contribute to CVD. FHS was under the direction of the National Heart Institute, now known as the National Heart, Lung, and Blood Institute.[2] Researchers followed the development of CHD over a long period in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke. The small town of Framingham in Massachusetts, USA was chosen due to its geographical proximity to the many cardiologists at Harvard Medical School. Furthermore, the residents had already participated in the Framingham tuberculosis demonstration study two decades earlier.[3]

The town of Framingham is located outside Boston. It was a small, middle-class community, and its small population made it an ideal site to launch the heart study. Everybody knew everyone. It was a typical small-town in the USA. The researchers hoped they would find clues in the medical histories of the people of Framingham which might shed light on causes of CVD. They recruited 5,209 men and women between the ages of 30 and 62 from the town of Framingham, Massachusetts. These study subjects underwent extensive physical examinations and lifestyle interviews that were analyzed for common patterns related to CVD development. Since 1948, the subjects have continued to return to the study every 2 years for a detailed medical history, physical examination, and laboratory tests, and in 1971, the study enrolled a second generation-5,124 of the original participants' adult children, and their spouses to participate in similar examinations.[2] The FHS is now on its third generation of participants. The study has provided substantial insight into the epidemiology of CVD and its risk factors.

Framingham study leads the way

The Framingham study was responsible for pointing out fallacies in our understanding of CVDs and identification of its major risk factors: high blood pressure, high blood cholesterol, smoking, obesity, diabetes, and physical inactivity as well as other valuable information on the effects of related factors such as blood triglyceride and high density lipoprotein (HDL) cholesterol levels, age, gender, and psychosocial issues. To date, no single risk factor has been identified to be responsible for causing CVD; rather, multiple interrelated factors seem responsible for its development. Although the Framingham cohort is Caucasian, other studies have shown that the major risk factors identified in this group apply universally to other racial and ethnic groups.

The notion of CVD risk factors is an integral part of modern medicine which has led to the development of effective treatment and preventive strategies in clinical practice.

Fallacies corrected

Physicians are sometimes taught some theories that are believed to be true without having been proven. These ideas or notions have been doctrines from centuries' old practices. Many of these concepts are taught us in medical school such as the notion that an elevated systolic blood pressure (BP) in the elderly is “normal,” which of course is false as I will discuss later. Then, a study comes along to dispel these erroneous ideas. Such a study was the Framingham heart study. Its epidemiological model of research has unraveled many of the fallacies in our understanding and helped to bring about a change in the way medicine is practiced.

The development of CHD through the prism of its major conventional cardiovascular risk factors – hypertension, hypercholesterolemia, smoking, and diabetes mellitus– is interesting, and hence, I will briefly look at how they evolved as risks through the “eyes” of the FHS and other epidemiological studies.

The major risk factors

There are many risk factors for CAD and some can be controlled but not others. The risk factors that can be controlled (modifiable) are: High BP; high blood cholesterol levels; smoking; diabetes; overweight or obesity; lack of physical activity; unhealthy diet and stress. Those that cannot be controlled (conventional) are: Age (simply getting older increases risk); sex (men are generally at greater risk of coronary artery disease); family history; and race.

Hypertension

Hypertension is one of the risks in the development of CHD. The American President Roosevelt died from cerebral hemorrhage, sequelae of hypertension.

Old myths corrected

Many old physicians thought that high BP was necessary to force blood through the stiffened arteries of older persons and that it was a normal element of aging. The medical community believed that a permissible systolic BP was 100 plus the participant's age in millimeters of mercury.[4],[5] For those aged >70 years, some considered the acceptable upper limits of normal BP to be 210 mmHg systolic and 120 mmHg diastolic.[6]

It was considered appropriate to ignore benign essential hypertension and isolated systolic hypertension. I remember that I was taught in medical school that diastolic pressure was a superior measure of blood pressure. The cardiovascular hazard of hypertension was believed to derive chiefly from the diastolic pressure component. Consequently, elevated systolic pressure was considered harmless, especially in the elderly.[7],[8]

FHS dispelled the concept of “benign essential hypertension.” Belief in the prime importance of the diastolic pressure was convincingly refuted by Framingham study data and later confirmed by other prospectively obtained data demonstrating that the impact of systolic pressure is actually greater than the diastolic component and that even isolated systolic hypertension is dangerous.[9],[10] FHS investigators found an increased risk of CAD morbidity with rising baseline blood pressure. They challenged the existing belief “that systolic pressure is unimportant, and that labile or benign essential hypertension is of little consequence.” They stated that there was “little evidence to support these contentions but considerable reason to doubt them.”[11]

The importance of controlling BP was finally embraced in practice guidelines in the first “Report of the Joint National Committee (JNC) on Detection, Evaluation, and Treatment of High Blood Pressure” in 1977.[12] It is now recognized universally that hypertension increases atherosclerotic CVD incidence; the risk burden is 2–3-fold. CAD is the most common sequelae for hypertensive patients of all ages.[13] Hypertension predisposes to all clinical manifestations of CHD including myocardial infarction, angina pectoris, and sudden death. Even high normal BP values are associated with an increased risk of CVD.[14]

It was thought that the risk ratio for intracerebral hemorrhage was greater than for atherothrombotic brain infarction. This was not true. It was found that hypertension was as strong a risk for atherothrombotic brain infarction as intracerebral hemorrhage.[11]

Framingham showed that the preponderance of hypertension-related strokes were atherothrombotic brain infarctions whether the hypertension was severe or mild. The proportion of strokes due to hemorrhage in mild hypertension was identical to that for severe hypertension.[4]

The Seventh JNC on hypertension established that those with BP of 120–139/80–89 mmHg are prehypertensives, that is, these individuals may become hypertensives in the future. Starting as low as 115/75 mmHg, the risk of heart attack and stroke doubles for every 20-point jump in systolic BP or every 10-point rise in diastolic BP for adults aged 40–70.

The presence of other risk factors for CVD such as high cholesterol, obesity, and diabetes is seen more in people with prehypertension than in those with normal blood pressure. The CVD risk in prehypertensives increases with the number of associated risk factors present. Therefore, prehypertension confers a greater risk for CVD.

In persons with mild to moderate hypertension, the substantial risk was shown to be concentrated in those with coexistent dyslipidemia, diabetes, and left ventricular hypertrophy. Hypertensive elderlies were commonly found to already have target organ damage such as impaired renal function, silent myocardial infarction, strokes, transient ischemic attacks, retinopathy, or peripheral artery disease. At least 60% of older men and 50% of elderly women with hypertension in the Framingham study had one or more of these conditions.[11]

In the past, initiation of antihypertensive treatment was often delayed until there was evidence of target organ involvement. Framingham study data indicated that this practice was unwise because 40%–50% of hypertensive persons developed overt cardiovascular events before evidence of target organ damage such as proteinuria, cardiomegaly, or electrocardiogram abnormalities.[11]

Various guidelines and numerous updates of guidelines on hypertension have been promulgated to improve its treatment and to prevent its adverse cardiovascular consequences. There is no cure for hypertension, but there are helpful pharmacological therapy and some strategies that a person can do to lower risk such as diet and exercise and checking BP regularly.

Hypercholesterolemia

The other major risk for CVD was cholesterol. In 1953, an association between cholesterol levels and CHD mortality was reported in various populations.[15] Animal and clinical observation have suggested such relationship. This association was confirmed by epidemiological studies showing a strong relation between serum total cholesterol and cardiovascular risk.[16],[17],[18]

It was shown that changes in cholesterol levels were associated with changes in CVD incidence rate.[19] Clinicians and epidemiologists accepted these findings, agreeing that total plasma cholesterol was a useful marker for predicting CVD. It was found that its component– the low-density lipoprotein cholesterol (LDL-C) which is the principal lipoprotein transporting cholesterol in the blood, was also directly associated with CVD.[20],[21],[22] It was also found out that LDL cholesterol levels in young adulthood predict development of CVD later in life.[22]

Current guidelines identify LDL-C as the primary target for high blood cholesterol therapy.[23] The benefits of LDL-C lowering drug therapies has been shown in various clinical, observational and experimental studies.[24] It has been shown that the benefits of reducing serum cholesterol for CHD risk are age-related: a 10% reduction in serum cholesterol produces a drop in CHD risk of 50% at the age of 40, 40% at age 50, 30% at age 60, and 20% at age 70.[25]

Now, high density lipoprotein cholesterol (HDL-C) is accepted by the medical community as an important factor in atherosclerosis and consequently, raising HDL-C has become an accepted therapeutic strategy for decreasing CHD incidence rate. There are some drugs that increase HDL-C such as fibrates, niacin, and torcetrapib, a cholesterol ester transfer protein but only fibrates have been shown to reduce risk of major coronary events. It is estimated that a 1 mg/dL increase in HDL level is associated with a decrease in coronary risk of 2% in men and 3% in women.[26]

Smoking

The Framingham study showed that smokers were at increased risk of myocardial infarction (MI) or sudden death and that risk was associated to the number of cigarettes smoked each day.[27] These results were confirmed by other epidemiological studies.[28],[29],[30] The deleterious effect of smoking on health has been proven in many studies, in particular on atherosclerosis.

The harmful effects of smoking on the heart can be appreciated in the following statistics:

  • Cigarette smoking approximately doubles the risk of morbidity and mortality from ischemic heart disease compared with a lifetime of not smoking, and the risk is related to the duration and amount of smoking.[31],[32]
  • There is evidence that in patients with CHD, smoking cessation reduces the risk of all-cause mortality and nonfatal MI.[33] Therefore, all patients with ischemic heart disease should be advised to stop smoking because it is a strong risk factor for a first MI and for fatal and nonfatal recurrences.
  • The risk of morbidity and mortality associated with cigarette smoking falls immediately after stopping smoking, although it may be >20 years, if at all, before the risk associated with smoking is completely reversed.[31],[34]
  • About 20% of patients will give up smoking after an acute MI with resultant 40% reduction in mortality rates and infarct recurrences.[35],[36]
  • For smokers under the age of 50 years the risk of developing CHD is 10 times greater than for nonsmokers of the same age.[37]
  • Passive smoking also increases the risk of CHD.[38]


Diabetes

The role of diabetes in the pathogenesis of CVD was unclear until 1979 when Kannel et al. used data from the Framingham heart study to identify diabetes as a major cardiovascular risk factor. Based on 20 years of surveillance of the Framingham cohort, a two-fold to threefold increased risk of clinical atherosclerotic disease was reported. It was also one of the first studies to demonstrate the higher risk of CVD in women with diabetes compared to men with diabetes.[39] These results have been duplicated by multiple studies. The Kannel article changed the way the medical community thought about diabetes. It is now accepted as a major cardiovascular risk factor. There is a clear-cut relationship between diabetes and CVD. The American Heart association cites the following statistics:[40]

  • At least 68% of people age 65 or older with diabetes die from some form of heart disease; and 16% die of stroke.
  • Adults with diabetes are two to four times more likely to die from heart disease than adults without diabetes.
  • The American Heart association considers diabetes to be one of the seven major controllable risk factors for CVD.


Diabetes is treatable but even if glucose levels are under control it greatly increases the risk of heart disease and stroke because people with diabetes also have other conditions that are risks for developing CHD such as hypertension, smoking, abnormal cholesterol, obesity, lack of physical activity, and metabolic syndrome. The good news is that by managing these risk factors, people with diabetes may avoid or delay the development of CVD.

Physical inactivity

“Conductors on London's double-decker buses (up and down stairs 11 days a fortnight, 50 weeks a year, often for decades) experienced half or less the incidence of acute MI and “sudden death” ascribed to CHD in the sedentary bus drivers.”[41] Thus, began Morris et al. in his landmark article in 1953 which appeared in The Lancet on the association of physical activity and coronary artery disease. Since then a number of epidemiological studies have confirmed the relationship. The relative risk of death from CHD for sedentary compared with active individuals is 1.9 (95% confidence interval).[42] The recommendation of physical exercise has become an important element of preventative policies for the general population (in adults, elderly, and children).

Obesity

The association of obesity and CHD was fist noted by Kannel et al.[43] in Framingham 50 years ago. Obesity is also an independent risk factor for all-cause mortality. It is a metabolic disorder associated with comorbidities such as CHD, type 2 diabetes, hypertension, and sleep apnea. Alterations in metabolic profile and various adaptations in cardiac structure and function occur as excess adipose tissue accumulates.[44] A recent study reported that higher body mass index (BMI) during childhood is associated with an increased risk of CHD in adulthood.[44]

The prevention and control of overweight and obesity in adults and children has become a key element for the prevention of cardiovascular diseases.[45],[46]

Cardiovascular diseases risk assessment

Absolute prediction of CVD risk of a person can be made using prediction charts issued or published by the WHO and ACC/AHA. The recommendations are made for management of major cardiovascular risk factors through changes in lifestyle and prophylactic drug therapies.

The ACC/AHA have produced guidelines for the procedures of detection, management, or prevention of CVD. In November 2013, The ACC and AHA released updated risk-assessment guidelines for atherosclerotic CVD. Changes and recommendations include the following.[47],[48],[49],[50],[51]

  • Stroke is added to the list of coronary events traditionally covered by risk prediction equations.
  • The guidelines focus primarily on the 10-year risk of atherosclerosis-related events; they focus secondarily on the assessment of lifetime risk for adults aged 59 or younger without high shorter-term risk.
  • The strongest predictors of 10-year risk are identified as age, sex, race, total cholesterol, HDL-C, blood pressure, blood-pressure treatment status, diabetes, and current smoking status.
  • Adjunct formulas for refining risk estimates by gender and race are provided.
  • If risk prediction needs to be further sharpened after risk prediction equations have been performed, the guidelines indicate that coronary-artery calcium scores, family history, high-sensitivity C-reactive protein, and the ankle-brachial index can be used.
  • The guidelines recommend that statin therapy be considered in individuals whose 10-year atherosclerotic cardiovascular disease (ASCVD) event risk is 7.5% or greater.


Guidelines from AHA/ACC recommend use of a revised calculator for estimating the 10-year risk of developing a first ASCVD event, which is defined as a nonfatal MI, death from CHD, or stroke (fatal or nonfatal) in a person who was initially free from ASCVD.[51] The calculator incorporates the following risk factors: sex, age, race, total cholesterol, HDL, systolic blood pressure, treatment for elevated blood pressure, diabetes, and smoking.

For patients 20–79 years of age who do not have existing clinical ASCVD, the guidelines recommend assessing clinical risk factors every 4–6 years. For patients with low 10-year risk (<7.5%), the guidelines recommend assessing 30-year or lifetime risk in patients 20–59-year-old.

The guidelines note that regardless of the patient's age, physicians should communicate risk data to the patient and refer to the AHA/ACC lifestyle guidelines, which cover diet and physical activity. For patients with elevated 10-year risk, physicians should communicate risk data and refer to the AHA/ACC guidelines on blood cholesterol and obesity.


   Summary Top


CVD is a major cause of disability and premature death throughout the world. The underlying pathology of atherosclerosis develops over many years and is usually advanced by the time symptoms occur, generally in middle age. The risk of developing CAD increases with age, and includes age >45 years in men and >55 years in women. A family history of early heart disease is also a risk factor, such as heart disease in the father or a brother diagnosed before age 55 years and in the mother or a sister diagnosed before age 65 years. Acute coronary and cerebrovascular events frequently occur suddenly, and are often fatal before medical care can be given. I have discussed above the major traditional risk factors.

Many traditional risk factors for CAD are related to lifestyle, therefore preventative treatment can be tailored to modifying specific factors. It is very important to know these risks to reduce disability and premature deaths from CHD, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event. People with established CVD are at very high risk of recurrent events.

Current guidelines provide advice on screening and identifying asymptomatic individuals at risk of developing CVD. The objectives of these guidelines are to reduce the incidence of first or recurrent clinical events due to CHD, ischemic stroke, and peripheral artery disease. The focus is on prevention of disability and early death. The guidelines emphasize the importance of lifestyle changes and use of different prophylactic drug therapies in the management of risks.

The understanding of such risk factors is critical to the prevention of cardiovascular morbidities and mortality.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham heart study and the epidemiology of cardiovascular disease: A historical perspective. Lancet 2014;383:999-1008.  Back to cited text no. 1
    
2.
Available from: http://www.framinghamheartstudy.org/about-fhs/history.php. Last accessed on 2017 Jun 12].  Back to cited text no. 2
    
3.
Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: The Framingham study. Am J Public Health Nations Health 1951;41:279-81.  Back to cited text no. 3
    
4.
Kannel WB. Fifty years of Framingham study contributions to understanding hypertension. J Hum Hypertens 2000;14:83-90.  Back to cited text no. 4
    
5.
Mickerson JN. Heart failure in hypertensive patients. Am Heart J 1963;65:267-74.  Back to cited text no. 5
    
6.
Caird FI. Heart disease in old age. Postgrad Med J 1963;39:408-20.  Back to cited text no. 6
    
7.
Harrison TR. Principles of Internal Medicine. 14 th ed. New York: McGraw-Hill; 1974.  Back to cited text no. 7
    
8.
Beeson PB, McDermott W. Cecil Loeb Textbook of Medicine. 5 th ed. Philadelphia: W.B. Saunders; 1963.  Back to cited text no. 8
    
9.
Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971;27:335-46.  Back to cited text no. 9
    
10.
Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham study. Circulation 1980;61:1179-82.  Back to cited text no. 10
    
11.
Kannel WB. Hypertension: Reflections on risks and prognostication. Med Clin North Am 2009;93:541-58.  Back to cited text no. 11
    
12.
Report of the joint national committee on detection, evaluation, and treatment of high blood pressure. A cooperative study. JAMA 1977;237:255-61.  Back to cited text no. 12
    
13.
Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 1995;18:181-96.  Back to cited text no. 13
    
14.
Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.  Back to cited text no. 14
    
15.
O'Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from Framingham heart study. Rev Esp Cardiol 2008;61:299-310.  Back to cited text no. 15
    
16.
Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project. The pooling project research group. J Chronic Dis 1978;31:201-306.  Back to cited text no. 16
    
17.
Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 1986;256:2823-8.  Back to cited text no. 17
    
18.
Anderson KM, Castelli WP, Levy D. Cholesterol and mortality 30 years of follow-up from the Framingham study. JAMA 1987;257:2176-80.  Back to cited text no. 18
    
19.
The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74.  Back to cited text no. 19
    
20.
Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966;34:679-97.  Back to cited text no. 20
    
21.
Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979;90:85-91.  Back to cited text no. 21
    
22.
Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313-8.  Back to cited text no. 22
    
23.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002;106:3143-421.  Back to cited text no. 23
    
24.
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr., Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39.  Back to cited text no. 24
    
25.
Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72.  Back to cited text no. 25
    
26.
Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.  Back to cited text no. 26
    
27.
Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA. Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med 1962;266:796-801.  Back to cited text no. 27
    
28.
Lakier JB. Smoking and cardiovascular disease. Am J Med 1992;93:8S-12S.  Back to cited text no. 28
    
29.
Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-4.  Back to cited text no. 29
    
30.
Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990;322:213-7.  Back to cited text no. 30
    
31.
Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: Baseline survey of provision in general practice. BMJ 1998;316:1430-4.  Back to cited text no. 31
    
32.
Cook DG, Shaper AG, Pocock SJ, Kussick SJ. Giving up smoking and the risk of heart attacks. A report from the British regional heart study. Lancet 1986;2:1376-80.  Back to cited text no. 32
    
33.
Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. JAMA 2003;290:86-97.  Back to cited text no. 33
    
34.
Wald NJ, Watt HC. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ 1997;314:1860-3.  Back to cited text no. 34
    
35.
Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: Final results of the Southampton heart integrated care project (SHIP). The SHIP collaborative group. BMJ 1999;318:706-11.  Back to cited text no. 35
    
36.
Wilhelmsen L. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking. Am Heart J 1988;115:242-9.  Back to cited text no. 36
    
37.
British Heart Foundation (Factfile 8/2001). Stopping Smoking – Evidence-Based Guidance. Available from: http://www.bhsoc.org/files/8213/4399/2345/bhf_factfile_aug_2001.pdf. [Last accessed on 2017 Jul 23].  Back to cited text no. 37
    
38.
British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association, et al. JBS 2: Joint British societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91 Suppl 5:v1-52.  Back to cited text no. 38
    
39.
Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-8.  Back to cited text no. 39
    
40.
Loud and Clear that there is a Strong Correlation Between Cardiovascular Disease (CVD) and Diabetes. Available from: http://www.heart.org/HEARTORG/Conditions/More/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp/speak. [Last accessed on 2017 Jul 25].  Back to cited text no. 40
    
41.
Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet 1953;265:1053-7.  Back to cited text no. 41
    
42.
Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612-28.  Back to cited text no. 42
    
43.
Kannel WB, LeBauer EJ, Dawber TR, McNamara PM. Relation of body weight to development of coronary heart disease. The Framingham study. Circulation 1967;35:734-44.  Back to cited text no. 43
    
44.
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.  Back to cited text no. 44
    
45.
Lama More RA, Alonso Franch A, Gil-Campos M, Leis Trabazo R, Martínez Suárez V, Moráis López A, et al. Childhood obesity. Recommendations of the nutrition committee of the Spanish association of pediatrics. Part I. Prevention. Early detection. Role of the pediatrician. An Pediatr (Barc) 2006;65:607-15.  Back to cited text no. 45
    
46.
U.S. Preventive Services Task Force. Screening for obesity in adults: Recommendations and rationale. Ann Intern Med 2003;139:930-2.  Back to cited text no. 46
    
47.
Available from: http://www.who.int/cardiovascular_diseases/guidelines. [Last accessed on 2017 Jul 23].  Back to cited text no. 47
    
48.
World Health Organization. Prevention of Recurrent Heart Attacks and Strokes in Low and Middle Income Populations. Evidence-Based Recommendations for Policy Makers and Health Professionals. Geneva; 2003. Available from: http://www.who.int/bookorders. [Last accessed on 2017 Jul 25].  Back to cited text no. 48
    
49.
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010;122:e584-636.  Back to cited text no. 49
    
50.
Cohen R, Budoff M, McClelland RL, Sillau S, Burke G, Blaha M, et al. Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the multi-ethnic study of atherosclerosis). Am J Cardiol 2014;114:1210-4.  Back to cited text no. 50
    
51.
Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S49-73.  Back to cited text no. 51
    



This article has been cited by
1 Estimation of the segmental left ventricular physical and mechanical parameters using echocardiographic imaging for stent candidate patients
Zeinab Alsadat Ahmadi, Manijhe Mokhtari Dizaji, Anita Sadeghpour, Hamideh Khesali, Ata Firouzi
Journal of Clinical Ultrasound. 2022;
[Pubmed] | [DOI]
2 Effects of intervention on lifestyle changes among coronary artery disease patients: A 6-month follow-up study
Pramila Gaudel, Subas Neupane, Anna-Maija Koivisto, Marja Kaunonen, Anja Rantanen
Nursing Open. 2022;
[Pubmed] | [DOI]
3 The correlation of long non-coding RNAs IFNG-AS1 and ZEB2-AS1 with IFN-? and ZEB-2 expression in PBMCs and clinical features of patients with coronary artery disease
Ali rafiei, Farnaz Khodabakhsh, Reza Ahangari Cohan, Fatemeh Azadegan-Dehkordi, Morteza Salimian
Molecular Biology Reports. 2022;
[Pubmed] | [DOI]
4 Forensic autopsy-confirmed thrombosis-related deaths: the danger in the bones
Walter J. Janse van Rensburg, Leriska Haupt
Journal of Thrombosis and Thrombolysis. 2022;
[Pubmed] | [DOI]
5 Contraception for Adolescents and Young Women with Type 2 Diabetes–Specific Considerations
Paulina M. Merino, Ethel Codner
Current Diabetes Reports. 2022;
[Pubmed] | [DOI]
6 Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
Ravi A. Thakker, Leonardo Salazar, Deaa Abu Jazar, Pooja Bhakta, Bryan Baker, Chandani Patel, Ayman Elbadawi, Mayank Agarwal, Aiham Albaeni, Mohammed Saleh, Jonathan Esclovan, Danielle El Haddad, Hashim Alwash, Ankur Kalra, Sachin S. Goel, Robert Jay Widmer, Khaled Chatila, Wissam Khalife, Afaq Motiwala, Jennifer McCracken, Hani Jneid, Syed Gilani
Cardiology and Therapy. 2022;
[Pubmed] | [DOI]
7 The efficacy of Zingiber officinale on dyslipidaemia, blood pressure, and inflammation as cardiovascular risk factors: A systematic review
Chelsea Courtney Daniels, Zaiyaan Isaacs, Renata Finelli, Kristian Leisegang
Clinical Nutrition ESPEN. 2022;
[Pubmed] | [DOI]
8 Longitudinal effects of lipid indices on incident cardiovascular diseases adjusting for time-varying confounding using marginal structural models: 25 years follow-up of two US cohort studies
Fatemeh Koohi, Davood Khalili, Hamid Soori, Maryam Nazemipour, Mohammad Ali Mansournia
Global Epidemiology. 2022; : 100075
[Pubmed] | [DOI]
9 Living donor liver transplantation in a cohort of recipients with left ventricular systolic dysfunction
Pooja Bhangui, Prashant Bhangui, Manish Aneja, Nishant Sharma, Nikunj Gupta, A.S. Soin, Vijay Vohra
Journal of Clinical and Experimental Hepatology. 2022;
[Pubmed] | [DOI]
10 Effect of losartan potassium, metformin hydrochloride, and simvastatin on in vitro bioaccessibility of Cu, Fe, Mn, and Zn in oat flour from Brazil
Wellington Correia de Carvalho, Thaís Luz de Sousa, Ana Cláudia Lima de Jesus, Laís Araújo Souza, Luana Cardoso dos Santos, Saul Vislei Simões da Silva, Daniele Cristina Muniz Batista Santos, Aníbal de Freitas Santos Júnior, Maria das Graças Andrade Korn
Journal of Trace Elements in Medicine and Biology. 2022; : 127032
[Pubmed] | [DOI]
11 Increased risk of coronary heart disease with hysterectomy in young women: A longitudinal follow-up study using a national health screening cohort
Hyo Geun Choi, Yoon Seok Koh, Suk Woo Lee
Maturitas. 2022; 157: 49
[Pubmed] | [DOI]
12 Why binge television viewing can be bad for you
Setor K. Kunutsor, Jari A. Laukkanen
Expert Review of Cardiovascular Therapy. 2022;
[Pubmed] | [DOI]
13 The Impact of Accelerated Diagnostic Protocol Implementation on Chest Pain Observation Unit Utilization
Iltifat Husain, Simon A. Mahler, Brian C. Hiestand, Chadwick D. Miller, Jason P. Stopyra
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 2022; 21(1): 7
[Pubmed] | [DOI]
14 Risk assessment indicators and brachial-ankle pulse wave velocity to predict atherosclerotic cardiovascular disease
Hung-Ju Ko, Chuan-Chuan Liu, Po-Jui Hsu, Kuang-Chun Hu, Chung-Lieh Hung, Lo-Yip Yu, Yun-Chieh Huang, Shou-Chuan Shih
Medicine. 2022; 101(32): e29609
[Pubmed] | [DOI]
15 Chrysin reduces hypercholesterolemia-mediated atherosclerosis through modulating oxidative stress, microflora, and apoptosis in experimental rats
Subramani Yuvaraj, Sundrasen Sasikumar, Shanavas Syed Mohamed Puhari, Tharmarajan Ramprasath, Nagarethinam Baskaran, Varadaraj Vasudevan, Govindan Sadasivam Selvam
Journal of Food Biochemistry. 2022;
[Pubmed] | [DOI]
16 Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China
Jinyu Su, Zhu Li, Mengnan Huang, Yang Wang, Tong Yang, Mei Ma, Tongyao Ni, Guangwei Pan, Ziqin Lai, Chunjie Li, Lin Li, Chunquan Yu
Cardiovascular Diabetology. 2022; 21(1)
[Pubmed] | [DOI]
17 Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting
Lionel Danny Nguefak Tali, Ghislaine Florice Nintewoue Faujo, Justine Laure Nguieguia Konang, Jean Paul Dzoyem, Laure Brigitte Mabeku Kouitcheu
BMC Infectious Diseases. 2022; 22(1)
[Pubmed] | [DOI]
18 Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort
Sukma Azureen Nazli, Yung-An Chua, Noor Alicezah Mohd Kasim, Zaliha Ismail, Ahmad Bakhtiar Md Radzi, Khairul Shafiq Ibrahim, Sazzli Shahlan Kasim, Azhari Rosman, Hapizah Nawawi, Xiao-Feng Yang
PLOS ONE. 2022; 17(9): e0273896
[Pubmed] | [DOI]
19 Knowledge of modifiable cardiovascular diseases risk factors and its primary prevention practices among diabetic patients at Jimma University Medical Centre: A cross-sectional study
Abdata Workina, Asaminew Habtamu, Tujuba Diribsa, Fikadu Abebe, Maurizio Trevisan
PLOS Global Public Health. 2022; 2(7): e0000575
[Pubmed] | [DOI]
20 Inequalities in the prevalence of cardiovascular disease risk factors in Brazilian slum populations: A cross-sectional study
Jasper J. L. Chan, Linh Tran-Nhu, Charlie F. M. Pitcairn, Anthony A. Laverty, Matías Mrejen, Julia M. Pescarini, Thomas V. Hone, Peter Bai James
PLOS Global Public Health. 2022; 2(9): e0000990
[Pubmed] | [DOI]
21 Effectiveness of a Nurse-Led Support Programme Using a Mobile Application versus Phone Advice on Patients at Risk of Coronary Heart Disease – A Pilot Randomized Controlled Trial
Eliza Mi Ling Wong, Doris Yin Ping Leung, Hon Lon Tam, Shuk Yee Ko, Angela Yee Man Leung, Simon Ching Lam, Ka Ching Cheung, Alice Siu Ping Cheung
Risk Management and Healthcare Policy. 2022; Volume 15: 597
[Pubmed] | [DOI]
22 Hemp Seeds, Flaxseed, and Açaí Berries: Health Benefits and Nutritional Importance with Emphasis on the Lipid Content
Pedro Magalhães, Rosário M. Domingues, Eliana Alves
Current Nutrition & Food Science. 2022; 18(1): 4
[Pubmed] | [DOI]
23 Genetic variations of renin-angiotensin and fibrinolytic systems and susceptibility to coronary artery disease: a population genetics perspective
Aysegul BAYRAMOGLU, Gokhan BAYRAMOGLU, Meral URHAN KUCUK, Halil I. GULER, Abdullah ARPACI
Minerva Cardiology and Angiology. 2022; 70(1)
[Pubmed] | [DOI]
24 Pooled prevalence of three major cardiovascular risk factors in patients undergoing left main bifurcation stenting: a systematic review and meta-analysis
Gianluca RIGATELLI, Marco ZUIN, Dobrin VASSILEV, Alberto MAZZA, Claudio BILATO, Loris RONCON
Minerva Cardiology and Angiology. 2022; 70(1)
[Pubmed] | [DOI]
25 Variations in coronary artery diameter: a retrospective observational study in Indian population
Rupali Mahajan B, Atul Atmaram A, Preeti Meshram, Nisha Vinod Ranadhir, Shantha Hattangadi
Heart, Vessels and Transplantation. 2022; 0(Ahead of P)
[Pubmed] | [DOI]
26 Differences in the number of stented coronary arteries based on the seven traditional obesity parameters among patients with coronary artery diseases undergoing cardiac catheterization
Audai A Hayajneh, Islam M Alhusban, Mohammad Rababa, Sami Al-Rawashdeh, Shatha Al-Sabbah, Dania Bani-Hamad
Electronic Journal of General Medicine. 2022; 19(5): em391
[Pubmed] | [DOI]
27 Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
Xu Wei, Yili Zhang, Chuanrui Sun, Baoyu Qi, Xinyi Huang, Ming Chen, Ning Liu, Kai Sun, Xin Chen, Xiaokuan Qin, Yanming Xie, Liguo Zhu
Frontiers in Cardiovascular Medicine. 2022; 9
[Pubmed] | [DOI]
28 Occupational Exposure to Poorly Soluble Low Toxicity Particles and Cardiac Disease: A Look at Carbon Black and Titanium Dioxide
Robert J. McCunney, Mei Yong, David B. Warheit, Peter Morfeld
Frontiers in Public Health. 2022; 10
[Pubmed] | [DOI]
29 Handgrip Strength-Related Factors in a Colombian Hypertensive Population: A Cross-Sectional Study
Yulieth Rivas-Campo, Elsa Patricia Muñoz-Laverde, Agustín Aibar-Almazán, José Daniel Jiménez-García, Antonio Martínez-Amat, Patricia Alexandra García-Garro, Juan Miguel Muñoz-Perete, Manuel Garcia-Sillero, Yolanda Castellote-Caballero
International Journal of Environmental Research and Public Health. 2022; 19(6): 3726
[Pubmed] | [DOI]
30 Bone Health in Patients with Dyslipidemias: An Underestimated Aspect
Panagiotis Anagnostis, Matilda Florentin, Sarantis Livadas, Irene Lambrinoudaki, Dimitrios G. Goulis
International Journal of Molecular Sciences. 2022; 23(3): 1639
[Pubmed] | [DOI]
31 Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms
Anastasia V. Poznyak, Nikolay K. Sadykhov, Andrey G. Kartuesov, Evgeny E. Borisov, Vasily N. Sukhorukov, Alexander N. Orekhov
International Journal of Molecular Sciences. 2022; 23(13): 6926
[Pubmed] | [DOI]
32 From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
Anastasia V. Poznyak, Larisa Litvinova, Paolo Poggio, Donato Moschetta, Vasily Nikolaevich Sukhorukov, Alexander N. Orekhov
International Journal of Molecular Sciences. 2022; 23(17): 9738
[Pubmed] | [DOI]
33 Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases
Jeyashree Alagarsamy, Anja Jaeschke, David Y. Hui
International Journal of Molecular Sciences. 2022; 23(17): 9892
[Pubmed] | [DOI]
34 Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases
May Nasser Bin-Jumah, Muhammad Shahid Nadeem, Sadaf Jamal Gilani, Bismillah Mubeen, Inam Ullah, Sami I. Alzarea, Mohammed M. Ghoneim, Sultan Alshehri, Fahad A. Al-Abbasi, Imran Kazmi
Antioxidants. 2022; 11(2): 232
[Pubmed] | [DOI]
35 The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
Ben Li, Muzammil H. Syed, Hamzah Khan, Krishna K. Singh, Mohammad Qadura
Biomedicines. 2022; 10(9): 2283
[Pubmed] | [DOI]
36 Sex Differences in Baseline Characteristics Do Not Predict Early Outcomes after Percutaneous Coronary Intervention: Results from the Australian GenesisCare Cardiovascular Outcomes Registry (GCOR)
Andre Conradie, Sinny Delacroix, MyNgan Duong, Nisha Schwarz, Enayet Chowdhury, Stephen Worthley, John Atherton, David Eccleston
Journal of Clinical Medicine. 2022; 11(4): 1138
[Pubmed] | [DOI]
37 Clinical Patterns of Traditional Chinese Medicine for Ischemic Heart Disease Treatment: A Population-Based Cohort Study
Lung-Shuo Wang, Pei-Tzu Yen, Shih-Feng Weng, Jong-Hau Hsu, Jwu-Lai Yeh
Medicina. 2022; 58(7): 879
[Pubmed] | [DOI]
38 Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study
Martino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, Daniele Andreini, Felicita Andreotti, Eleuterio Ferrannini, Roberto Latini, Aldo P. Maggioni, Marco Magnoni, Giuseppe Mercuro
Metabolites. 2022; 12(2): 123
[Pubmed] | [DOI]
39 Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
Ehsan Ullah, Ayman El-Menyar, Khalid Kunji, Reem Elsousy, Haira R. B. Mokhtar, Eiman Ahmad, Maryam Al-Nesf, Alka Beotra, Mohammed Al-Maadheed, Vidya Mohamed-Ali, Mohamad Saad, Jassim Al Suwaidi
Metabolites. 2022; 12(6): 517
[Pubmed] | [DOI]
40 PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction
Meidi Utami Puteri, Nuriza Ulul Azmi, Mitsuyasu Kato, Fadlina Chany Saputri
Life. 2022; 12(2): 190
[Pubmed] | [DOI]
41 Atherogenic Index of Plasma and Its Association with Risk Factors of Coronary Artery Disease and Nutrient Intake in Korean Adult Men: The 2013–2014 KNHANES
Hye Ran Shin, SuJin Song, Jin Ah Cho, Sun Yung Ly
Nutrients. 2022; 14(5): 1071
[Pubmed] | [DOI]
42 Vital Signs Monitoring Based on Interferometric Fiber Optic Sensors
Weimin Lyu, Shuyang Chen, Fengze Tan, Changyuan Yu
Photonics. 2022; 9(2): 50
[Pubmed] | [DOI]
43 Clinical Significance of Monocyte Chemoattractant Protein-1 and CC Chemokine Receptor Type 2 Gene Polymorphisms in Young Patients with Acute Coronary Syndrome
Mustafa Begenç TASCANOV, Senol ÇITLI
Harran Üniversitesi Tip Fakültesi Dergisi. 2022; : 272
[Pubmed] | [DOI]
44 The use of screening tools for cardiovascular risk assessment in psoriasis – A case- control study
Shekhar Neema, Sunmeet Sandhu, Biju Vasudevan, Senkadhir Vendhan D, Anwita Sinha, DurgaM Tripathy, Seema Patrikar
Indian Dermatology Online Journal. 2022; 13(1): 46
[Pubmed] | [DOI]
45 Correlation of Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with serum GDF-15 in a group of hypertensive Iraqi patients
Roaa Hatem Al Gburi, Raid D. Hashim, Hayder Ahmed Kadhim, Sevki Adam, Haider Abdulkareem Almashhadani
Research Journal of Pharmacy and Technology. 2022; : 3466
[Pubmed] | [DOI]
46 Knowledge, Attitude, and Practice Toward Cardiovascular Diseases in the Lebanese Population
Marc Machaalani, Battoul Fakhry, Maisoon Zwaihed, Karl Mendelek, Nadine Mahmoud, Talal Hammoud, Mirna N. Chahine
Global Heart. 2022; 17(1)
[Pubmed] | [DOI]
47 Acute coronary syndrome: role of the nurse in patient assessment and management
Alison Malecki-Ketchell
Nursing Standard. 2022;
[Pubmed] | [DOI]
48 Assessment of Right Ventricular Function in Patients With Acute Myocardial Infarction
Praveen K Baghel, Sunil K Tripathi, Althaf A Vahab, Puneet Aggarwal
Cureus. 2022;
[Pubmed] | [DOI]
49 Incidence of Coronary Artery Disease in King Abdulaziz University Hospital, Jeddah, Saudi Arabia, 2019–2020: A Retrospective Cohort Study
Fatma Albeladi, Iman Wahby Salem, Mohammed Zahrani, Layal Alarbedi, Abdulrahman Abukhudair, Huda Alnafei, Abeer Alraiqi, Nourah Alyoubi
Cureus. 2022;
[Pubmed] | [DOI]
50 Hair Lead, Aluminum, and Other Toxic Metals in Normal-Weight and Obese Patients with Coronary Heart Disease
Anatoly V. Skalny,Philippe Yu Kopylov,Monica M. B. Paoliello,Jung-Su Chang,Michael Aschner,Igor P. Bobrovnitsky,Jane C.-J. Chao,Jan Aaseth,Sergei N. Chebotarev,Alexey A. Tinkov
International Journal of Environmental Research and Public Health. 2021; 18(15): 8195
[Pubmed] | [DOI]
51 Coronary Artery Calcium Score - A Reliable Indicator of Coronary Artery Disease?
Devarashetty Shreya, Diana I Zamora, Gautami S Patel, Idan Grossmann, Kevin Rodriguez, Mridul Soni, Pranay K Joshi, Saawan C Patel, Ibrahim Sange
Cureus. 2021;
[Pubmed] | [DOI]
52 Evaluation of the Relationship between Hematological Indices and Cardiovascular Events in Isfahan Cohort Study
Atieh Jafari, Azam Soleimani, Masoumeh Sadeghi, Hamidreza Roohafza, Mohammad Talaei, Minoo Dianatkhah, Nizal Sarrafzadegan
Avicenna Journal of Clinical Medicine. 2021; 28(3): 151
[Pubmed] | [DOI]
53 A Machine Learning Approach for Heart Attack Prediction
Suraj Kumar Gupta, Aditya Shrivastava, Satya Prakash Upadhyay, Pawan Kumar Chaurasia*
International Journal of Engineering and Advanced Technology. 2021; 10(6): 124
[Pubmed] | [DOI]
54 KNOWLEDGE REGARDING RISK FACTORS AND PREVENTION OF CORONARY ARTERY DISEASE (CAD) AMONG BANK WORKERS OF BANKS: A PREEXPERIMENTAL STUDY
Suhasinee Alias,Sudha Reddi
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2021; : 39
[Pubmed] | [DOI]
55 The Risk Factors of Coronary Heart Disease and its Relationship with Endothelial Nitric Oxide Synthase
Eka Fithra Elfi,Eva Decroli,Ellyza Nasrul,Yanwirasti Yanwirasti,Eryati Darwin
Open Access Macedonian Journal of Medical Sciences. 2021; 9(B): 451
[Pubmed] | [DOI]
56 Determinants of Coronary Heart Disease Incidence among Indonesian Hajj Pilgrims Hospitalized in Saudi Arabia in 2019
Juniarty Naim, Wahiduddin Wahiduddin, Masni Masni, Ridwan Amiruddin, Irwandy Irwandy, M. Nadjib Bustan
Open Access Macedonian Journal of Medical Sciences. 2021; 9(E): 798
[Pubmed] | [DOI]
57 Quantitative determination of EPA and DHA in fish oil capsules for cardiovascular disease therapy in Indonesia by GC-MS
Amelia Lorensia,Ryanto Budiono,Rivan Virlando Suryadinata,Navy Tiarasari
Journal of Public Health Research. 2021; 10(2)
[Pubmed] | [DOI]
58 Diabesity lipid index: A potential novel marker of 10-year cardiovascular risk
TaoreedAdegoke Azeez
Vascular Investigation and Therapy. 2021; 4(3): 70
[Pubmed] | [DOI]
59 The Expression of Allele Changes in NLRP3 (rs35829419) and IL-1ß (+3954) Gene Polymorphisms in Periodontitis and Coronary Artery Disease
Jaideep Mahendra, Abirami Nayaki Rao, Little Mahendra, Mohammed E. Sayed, Maryam H. Mugri, Thodur Madapusi Balaji, Saranya Varadarajan, Raghunathan Jagannathan, Sruthi Srinivasan, Hosam Ali Baeshen, Reji Mathew, Shankargouda Patil
Materials. 2021; 14(17): 5103
[Pubmed] | [DOI]
60 Cross-Sectional Study of Plant Sterols Intake as a Basis for Designing Appropriate Plant Sterol-Enriched Food in Indonesia
Drajat Martianto,Atikah Bararah,Nuri Andarwulan,Dominika Srednicka-Tober
Nutrients. 2021; 13(2): 452
[Pubmed] | [DOI]
61 A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study
Angelica P. Ahrens, Tyler Culpepper, Brittany Saldivar, Stephen Anton, Scott Stoll, Eileen M. Handberg, Ke Xu, Carl Pepine, Eric W. Triplett, Monica Aggarwal
Nutrients. 2021; 13(10): 3459
[Pubmed] | [DOI]
62 The Effects of Anthocyanin-Rich Bilberry Extract on Transintestinal Cholesterol Excretion
Jimin Hong, Minji Kim, Bohkyung Kim
Foods. 2021; 10(11): 2852
[Pubmed] | [DOI]
63 Factors Affecting the Intention to Modify Lifestyle in the Cardiovascular Disease Risk Group in Korea
JaeLan Shim,KyungAe Kim
Healthcare. 2021; 9(5): 496
[Pubmed] | [DOI]
64 Genetic Polymorphisms of NLRP3 (rs4612666) and CARD8 (rs2043211) in Periodontitis and Cardiovascular Diseases
Jaideep Mahendra,Abirami Nayaki Rao,Little Mahendra,Hytham N. Fageeh,Hammam Ibrahim Fageeh,Thodur Madapusi Balaji,Saranya Varadarajan,Raghunathan Jagannathan,Deepak Mehta,Venkata V. Suresh,A. Thirumal Raj,Shankargouda Patil
Biology. 2021; 10(7): 592
[Pubmed] | [DOI]
65 Endometriosis Is Associated with an Increased Risk of Coronary Artery Disease in Asian Women
Pei-Chen Li, Yu-Cih Yang, Jen-Hung Wang, Shinn-Zong Lin, Dah-Ching Ding
Journal of Clinical Medicine. 2021; 10(18): 4173
[Pubmed] | [DOI]
66 Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis
Ahmed M. Hedar, Martin H. Stradner, Andreas Roessler, Nandu Goswami
Journal of Clinical Medicine. 2021; 10(19): 4427
[Pubmed] | [DOI]
67 The Impact of Advance Directive Perspectives on the Completion of Life-Sustaining Treatment Decisions in Patients with Heart Failure: A Prospective Study
JinShil Kim, Seongkum Heo, Bong Roung Kim, Soon Yong Suh, Jae Lan Shim, Minjeong An, Mi-Seung Shin
Journal of Clinical Medicine. 2021; 10(24): 5962
[Pubmed] | [DOI]
68 Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
Kevin M. Casin,John W. Calvert
Antioxidants. 2021; 10(3): 383
[Pubmed] | [DOI]
69 Plasma Oxylipins: A Potential Risk Assessment Tool in Atherosclerotic Coronary Artery Disease
D. Elizabeth Le,Manuel García-Jaramillo,Gerd Bobe,Armando Alcazar Magana,Ashish Vaswani,Jessica Minnier,Donald B. Jump,Diana Rinkevich,Nabil J. Alkayed,Claudia S. Maier,Sanjiv Kaul
Frontiers in Cardiovascular Medicine. 2021; 8
[Pubmed] | [DOI]
70 Clusters of the Risk Markers and the Pattern of Premature Coronary Heart Disease: An Application of the Latent Class Analysis
Leila Jahangiry, Mahdieh Abbasalizad Farhangi, Mahdi Najafi, Parvin Sarbakhsh
Frontiers in Cardiovascular Medicine. 2021; 8
[Pubmed] | [DOI]
71 Combined lipid-lowering therapy from standpoint of modern guidelines for management of dyslipidaemias
O. D. Ostroumova, A. I. Kochetkov, A. I. Listratov
Medical alphabet. 2021; (17): 13
[Pubmed] | [DOI]
72 The relationship between the exercise capacity and somatotype components, body composition, and quadriceps strength in individuals with coronary artery disease
Melike Gültekin, Gülay Yeginoglu, Hasan Bingöl
Journal of Clinical Medicine of Kazakhstan. 2021; 18(6): 62
[Pubmed] | [DOI]
73 Usability of Wireless ECG Body Sensor for Cardiac Function Monitoring During Field Testing
Boris Širaiy,Vladimir Ilic,Lazar Toskic
Measurement Science Review. 2021; 21(2): 55
[Pubmed] | [DOI]
74 Cardiovascular risk in primary care: comparison between Framingham Score and waist circumference
Nina Vitória de Souza Silva Andrade, Isis Marinho de Noronha, Larisse Xavier Almeida, Fernanda Siqueira, Tatiana Onofre
REVISTA CIÊNCIAS EM SAÚDE. 2021; 11(4): 53
[Pubmed] | [DOI]
75 Sex differences in total cholesterol of Vietnamese adults
Nga Thi Thu Tran, Christopher Leigh Blizzard, Khue Ngoc Luong, Ngoc Le Van Ngoc Truong, Bao Quoc Tran, Petr Otahal, Mark R. Nelson, Costan G. Magnussen, Tan Van Bui, Velandai Srikanth, Thuy Bich Au, Son Thai Ha, Hai Ngoc Phung, Mai Hoang Tran, Michele Callisaya, Seana Gall, Lee-Ling Lim
PLOS ONE. 2021; 16(8): e0256589
[Pubmed] | [DOI]
76 The effect of paraoxonase 1 (PON1) gene polymorphisms T(-107)C and L55M and diet composition on serum PON1 activity in women
Bianka Machado Zanini, Leticia Burkert, Fabiola Goettem dos Santos, Michal M. Masternak, José Augusto Crespo-Ribeiro, Carlos Castilho Barros, Sandra Costa Valle, Augusto Schneider
Archives of Endocrinology and Metabolism. 2021;
[Pubmed] | [DOI]
77 Machine learning algorithms for predicting coronary artery disease: efforts toward an open source solution
Aravind Akella,Sudheer Akella
Future Science OA. 2021; 7(6): FSO698
[Pubmed] | [DOI]
78 Prognostic Implication of Stress Induced Hyperglycemia in Non Diabetic Patients with Acute Coronary Syndrome
Sanjay Tukaram Thorat, , Radhika Ratanlal Bajaj, Vaibhav Vijay Rane, Avanti Jayant Damle, Nikhil Dilip Patil, Pankaj Nivrutti Pawar
Journal of Evolution of Medical and Dental Sciences. 2021; 10(45): 3931
[Pubmed] | [DOI]
79 The serum levels of testosterone in coronary artery disease patients; relation to NO, eNOS, endothelin-1, and disease severity
Saeideh Akseh, Mohammad-Ali Karimi, Nasser Safaie, Amir Valizadeh, Dara Rahmanpour, Masoud Pezeshkian, Mohammad Nouri, Yousef Faridvand, Ahmadreza Jodati
Hormone Molecular Biology and Clinical Investigation. 2021; 0(0)
[Pubmed] | [DOI]
80 Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
Maria Isabel Mendonça,Eva Henriques,Sofia Borges,Ana Célia Sousa,Andreia Pereira,Marina Santos,Margarida Temtem,Sónia Freitas,Joel Monteiro,João Adriano Sousa,Ricardo Rodrigues,Graça Guerra,Roberto Palma dos Reis
Genetics and Molecular Biology. 2021; 44(2)
[Pubmed] | [DOI]
81 The effect of IgG fraction from blood plasma of patients with acute coronary syndromes on the parameters of primary haemostasis
T. Marynenko, T. Halenova, L. Ostapchenko
Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology. 2021; (87): 27
[Pubmed] | [DOI]
82 New susceptibility alleles associated with severe coronary artery stenosis in the Lebanese population
Victor Wakim,Elie Abi Khalil,Angelique K. Salloum,Georges Khazen,Michella Ghassibe-Sabbagh,Pierre A. Zalloua
BMC Medical Genomics. 2021; 14(1)
[Pubmed] | [DOI]
83 The optimal WC cut-off points for the prediction of subclinical CVD as measured by carotid intima-media thickness among African adults: a cross-sectional study
M. C. Ringane, S. S. R. Choma
BMC Cardiovascular Disorders. 2021; 21(1)
[Pubmed] | [DOI]
84 Effect of guidewire insertion in fractional flow reserve procedure for real geometry using computational fluid dynamics
Yasser Abuouf, Muhamed AlBadawi, Shinichi Ookawara, Mahmoud Ahmed
BioMedical Engineering OnLine. 2021; 20(1)
[Pubmed] | [DOI]
85 An Integrated Machine Learning Framework for Effective Prediction of Cardiovascular Diseases
Aqsa Rahim,Yawar Rasheed,Farooque Azam,Muhammad Waseem Anwar,Muhammad Abdul Rahim,Abdul Wahab Muzaffar
IEEE Access. 2021; 9: 106575
[Pubmed] | [DOI]
86 A hybrid recurrent neural network - logistic chaos-based whale optimization framework for heart disease prediction with electronic health records
P. Priyanga,Veena V. Pattankar,S. Sridevi
Computational Intelligence. 2021; 37(1): 315
[Pubmed] | [DOI]
87 Coronary calcification is associated with elevated serum lipoprotein (a) levels in asymptomatic men over the age of 45 years
Young Hak Chung,Byoung-Kwon Lee,Hyuck Moon Kwon,Pil-Ki Min,Eui-Young Choi,Young Won Yoon,Bum-Kee Hong,Se-Joong Rim,Jong-Youn Kim
Medicine. 2021; 100(9): e24962
[Pubmed] | [DOI]
88 Effects of Danhong injection on cardiac function and blood lipid in patients with angina pectoris of coronary heart disease
Jian Liang, Xiaojiao He, Hongyu Zhou, Peng Liang
Medicine. 2021; 100(43): e27479
[Pubmed] | [DOI]
89 Contribution of lncRNA CASC8, CASC11, and PVT1 Genetic Variants to the Susceptibility of Coronary Heart Disease
Yan Lu,Wei Yuan,Lan Wang,Mingan Ning,Yuan Han,Wenjuan Gu,Tingting Zhao,Fenqing Shang,Xuan Guo
Journal of Cardiovascular Pharmacology. 2021; 77(6): 756
[Pubmed] | [DOI]
90 Adherence to guideline-recommended HbA1c testing frequency and better outcomes in patients with type 2 diabetes: a 5-year retrospective cohort study in Australian general practice
Chisato Imai, Ling Li, Rae-Anne Hardie, Andrew Georgiou
BMJ Quality & Safety. 2021; 30(9): 706
[Pubmed] | [DOI]
91 Relative Impact of Clinical Risk Versus Procedural Risk on Clinical Outcomes After Percutaneous Coronary Intervention
Jeehoon Kang,Kyung Woo Park,Hak Seung Lee,Chengbin Zheng,Tae-Min Rhee,You-Jeong Ki,Mineok Chang,Jung-Kyu Han,Han-Mo Yang,Hyun-Jae Kang,Bon-Kwon Koo,Hyo-Soo Kim
Circulation: Cardiovascular Interventions. 2021; 14(2)
[Pubmed] | [DOI]
92 Extent of Coronary Artery Disease in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valves
Onur B. Dolmaci,Juno Legué,Jan H. N. Lindeman,Antoine H. G. Driessen,Robert J. M. Klautz,Thomas J. Van Brakel,Hans-Marc J. Siebelink,Bart J. A. Mertens,Robert E. Poelmann,Adriana C. Gittenberger-de Groot,Nimrat Grewal
Journal of the American Heart Association. 2021; 10(12)
[Pubmed] | [DOI]
93 Supporting Real World Decision Making in Coronary Diseases Using Machine Learning
Peter Kokol, Jan Jurman, Tajda Bogovic, Tadej Završnik, Jernej Završnik, Helena Blažun Vošner
INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2021; 58: 0046958021
[Pubmed] | [DOI]
94 Cardiovascular Risk Factors in Colombian Penitentiary Staff: An Interdisciplinary View of a High-Risk Occupation
Luz Mery Contreras-Ramos, Omar Alberto Domínguez Amorocho
Hispanic Health Care International. 2021; : 1540415321
[Pubmed] | [DOI]
95 Validation and comparison of 28 risk prediction models for coronary artery disease
Chris Lenselink,Daan Ties,Rick Pleijhuis,Pim van der Harst
European Journal of Preventive Cardiology. 2021;
[Pubmed] | [DOI]
96 Modelling the spread of atherosclerosis considering relapse and linear treatment
A Islamilova,D Aldila,W Giyarti,H Tasman
Journal of Physics: Conference Series. 2021; 1722: 012039
[Pubmed] | [DOI]
97 A Numerical Analysis of Blood Flow in Clogged Artery
Nilesh Sahu,Ayush Sharama,Pankaj Kumar
Journal of Physics: Conference Series. 2021; 1964(6): 062102
[Pubmed] | [DOI]
98 The Degradation of G3BP2 by Trim-away Method Inhibits Oscillatory Shear Stress induced Endothelial Cell Inflammation
M Safitri,T Li,M A E M Sihombing,J Qiu,G Wang
IOP Conference Series: Earth and Environmental Science. 2021; 741(1): 012066
[Pubmed] | [DOI]
99 The global prevalence of Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus and Herpes simplex virus in patients with coronary artery disease: A systematic review and meta-analysis
Masoud Dadashi,Bahareh Hajikhani,Mona Ghazi,Shahrooz Yazdani,Mehdi Goudarzi,Mohammad Javad Nasiri,Shervin Shokouhi,Parviz Owlia,Somayeh Yaslianifard
Microbial Pathogenesis. 2021; 152: 104572
[Pubmed] | [DOI]
100 Effects of guar gum supplementation on the lipid profile: A systematic review and meta-analysis of randomized controlled trials
Jianbei Lin, Yan Sun, Heitor O. Santos, Mihnea-Alexandru Gaman, Latha T. Bhat, Yan Cui
Nutrition, Metabolism and Cardiovascular Diseases. 2021; 31(12): 3271
[Pubmed] | [DOI]
101 Examining Acute Coronary Syndrome Across Ethnicity, Sex, and Age
Kristofer De Leon, Elizabeth J. Winokur
The Journal for Nurse Practitioners. 2021;
[Pubmed] | [DOI]
102 In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
Muhammad Bilal Azmi,Saleha Sultana,Sadaf Naeem,Shamim Akhtar Qureshi
Saudi Journal of Biological Sciences. 2021; 28(1): 731
[Pubmed] | [DOI]
103 Unmet Medical Need as a Driver for Pharmaceutical Sciences – A Survey Among Scientists
Z. Kusynová, G.M. Pauletti, H.A van den Ham, H.G.M. Leufkens, A.K. Mantel-Teeuwisse
Journal of Pharmaceutical Sciences. 2021;
[Pubmed] | [DOI]
104 An evaluation of lipid profile and pro-inflammatory cytokines as determinants of cardiovascular disease in those with diabetes: a study on a Mexican American cohort
Amna Tahir,Perla J. Martinez,Fayyaz Ahmad,Susan P. Fisher-Hoch,Joseph McCormick,Jennifer L. Gay,Shaper Mirza,Safee Ullah Chaudhary
Scientific Reports. 2021; 11(1)
[Pubmed] | [DOI]
105 Effects of data preprocessing on results of the epidemiological analysis of coronary heart disease and behaviour-related risk factors
Ari Voutilainen,Christina Brester,Mikko Kolehmainen,Tomi-Pekka Tuomainen
Annals of Medicine. 2021; 53(1): 890
[Pubmed] | [DOI]
106 Ultra-processed foods consumption is associated with cardiovascular disease and cardiometabolic risk factors in Brazilians with established cardiovascular events
Alessandra da Silva,Matheus Brum Felício,Ana Paula Silva Caldas,Helen Hermana Hermsdorff,Camila Ragne Torreglosa,Ângela Cristine Bersch-Ferreira,Bernardete Weber,Aline Marcadenti,Josefina Bressan
International Journal of Food Sciences and Nutrition. 2021; : 1
[Pubmed] | [DOI]
107 Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
Hamideh Amirfakhryan,Fatemeh safari
Hellenic Journal of Cardiology. 2021; 62(1): 13
[Pubmed] | [DOI]
108 The relationship of lipid peroxidation and antioxidant status to selected modifiable risk factors in coronary artery disease patients
Anoop Vijayan,V. Chithra,C. Sandhya
International Journal of Cardiology Hypertension. 2021; 8: 100077
[Pubmed] | [DOI]
109 A hybrid approach for mortality prediction for heart patients using ACO-HKNN
C. Sowmiya,P. Sumitra
Journal of Ambient Intelligence and Humanized Computing. 2021; 12(5): 5405
[Pubmed] | [DOI]
110 Evaluation of ERRFI1 +808 T/G variant and its mRNA expression in coronary artery in-stent restenosis
Maryam Mehrpooya,Saeedeh Asgarbeik,Aida Vahidi,Mahsa Mohammad Amoli,Seyed Kianoosh Hosseini
Gene Reports. 2021; 24: 101248
[Pubmed] | [DOI]
111 Convolutional and recurrent neural networks for the detection of valvular heart diseases in phonocardiogram recordings
Mohanad Alkhodari,Luay Fraiwan
Computer Methods and Programs in Biomedicine. 2021; 200: 105940
[Pubmed] | [DOI]
112 Histamine 2 receptors in cardiovascular biology: A friend for the heart
Sherin Saheera, Ajay Godwin Potnuri, Ashrith Guha, Suresh S. Palaniyandi, Rajarajan A. Thandavarayan
Drug Discovery Today. 2021;
[Pubmed] | [DOI]
113 Strengthening the Case for Cluster Set Resistance Training in Aged and Clinical Settings: Emerging Evidence, Proposed Benefits and Suggestions
Christopher Latella,Carolyn Peddle-McIntyre,Lauren Marcotte,James Steele,Kristina Kendall,Ciaran M. Fairman
Sports Medicine. 2021; 51(7): 1335
[Pubmed] | [DOI]
114 Cannabis Use and Electrocardiographic Myocardial Injury
Travis M. Skipina,Bharathi Upadhya,Elsayed Z. Soliman
The American Journal of Cardiology. 2021; 151: 100
[Pubmed] | [DOI]
115 Investigation of climate change impacts on long-term care facility occupants
Sara Wollschlaeger, Ayan Sadhu, Ghazal Ebrahimi, Angie Woo
City and Environment Interactions. 2021; : 100077
[Pubmed] | [DOI]
116 A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease
Jonathan Zhi Kai Toh, Xin-Hui Pan, Phoebe Wen Lin Tay, Cheng Han Ng, Jie Ning Yong, Jieling Xiao, Jin Hean Koh, En Ying Tan, Eunice Xiang Xuan Tan, Yock Young Dan, Poay Huan Loh, Roger Foo, Nicholas W.S. Chew, Arun J. Sanyal, Mark D. Muthiah, Mohammad Shadab Siddiqui
Clinical Gastroenterology and Hepatology. 2021;
[Pubmed] | [DOI]
117 The Effect of Laparoscopic Sleeve Gastrectomy on Subclinical Atherosclerosis in Patients with Severe Obesity
Yusuf Cekici,Bedri Caner Kaya,Hasan Elkan
Obesity Surgery. 2021; 31(2): 738
[Pubmed] | [DOI]
118 The effectiveness of planned discharge education on health knowledge and beliefs in patients with acute myocardial infarction: a randomized controlled trial
Serap Tuna,Sezgi Çinar Pakyüz
Irish Journal of Medical Science (1971 -). 2021;
[Pubmed] | [DOI]
119 Personalized Recommendation Method for Preventing Elderly People from Cardiovascular Disease Complication Using Integrated Objective Distance
Supansa Chaising,Ramjee Prasad,Punnarumol Temdee
Wireless Personal Communications. 2021; 117(1): 215
[Pubmed] | [DOI]
120 Uncurtaining the pivotal role of ABC transporters in diabetes mellitus
Tapan Behl,Aayush Sehgal,Madhuri Grover,Sukhbir Singh,Neelam Sharma,Saurabh Bhatia,Ahmed Al-Harrasi,Lotfi Aleya,Simona Bungau
Environmental Science and Pollution Research. 2021;
[Pubmed] | [DOI]
121 Association between satellite-based estimates of long-term PM2.5 exposure and cardiovascular disease: evidence from the Indonesian Family Life Survey
Sepridawati Siregar, Nora Idiawati, Wen-Chi Pan, Kuo-Pin Yu
Environmental Science and Pollution Research. 2021;
[Pubmed] | [DOI]
122 Phytotherapy with active tea constituents: a review
Ajay Rana,Shalika Rana,Sanjay Kumar
Environmental Chemistry Letters. 2021; 19(3): 2031
[Pubmed] | [DOI]
123 Chrysin attenuates high-fat-diet-induced myocardial oxidative stress via upregulating eNOS and Nrf2 target genes in rats
Subramani Yuvaraj,Tharmarajan Ramprasath,Balakrishnan Saravanan,Varadaraj Vasudevan,Sundaresan Sasikumar,Govindan Sadasivam Selvam
Molecular and Cellular Biochemistry. 2021; 476(7): 2719
[Pubmed] | [DOI]
124 Feature selection and risk prediction for patients with coronary artery disease using data mining
Nashreen Md Idris,Yin Kia Chiam,Kasturi Dewi Varathan,Wan Azman Wan Ahmad,Kok Han Chee,Yih Miin Liew
Medical & Biological Engineering & Computing. 2020; 58(12): 3123
[Pubmed] | [DOI]
125 Role of Aspirin for Primary Prevention in Persons with Diabetes Mellitus and in the Elderly
Neha J. Patel,Ragavendra R. Baliga
Current Cardiology Reports. 2020; 22(7)
[Pubmed] | [DOI]
126 Study of the relationship between endothelial lipase gene polymorphism and serum levels of HDL-C, Apo A-I and severity of stenosis in non-diabetic coronary artery disease patients
Zohre Afshoon,Alireza Bahiraee,Fataneh Esmaeili,Elaheh Mansouri,Mohammad Amin Emami,Maryam Montaseri,Nahid Davoodian,Reyhane Ebrahimi,Ebrahim Eftekhar
Gene Reports. 2020; 21: 100831
[Pubmed] | [DOI]
127 Association between genetic variants at chromosome 9p21 and risk of coronary artery disease in Emirati Type 2 Diabetes patients
Zahrah Baalfaqih,Fatima Sulaiman,Nadia Abu-Samra,Manar Alshaikh,Aurelie Mawart,Wael Osman,Wael Al Mahmeed,Guan Tay,Habiba Alsafar
Gene Reports. 2020; 21: 100892
[Pubmed] | [DOI]
128 Analysis of the effect of guidewire position on stenosis diagnosis using computational fluid dynamics
Yasser Abuouf,Shinichi Ookawara,Mahmoud Ahmed
Computers in Biology and Medicine. 2020; 121: 103777
[Pubmed] | [DOI]
129 Novel Point Mutations in Mitochondrial MT-CO2 Gene May Be Risk Factors for Coronary Artery Disease
Mohammad Mehdi Heidari,Fatemeh Sadat Mirfakhradini,Fahime Tayefi,Saghar Ghorbani,Mehri Khatami,Mehdi Hadadzadeh
Applied Biochemistry and Biotechnology. 2020; 191(3): 1326
[Pubmed] | [DOI]
130 miRNA polymorphisms and risk of premature coronary artery disease
Konstantinos Agiannitopoulos,Pinelopi Samara,Miranta Papadopoulou,Astradeni Efthymiadou,Eirini Papadopoulou,Georgios N. Tsaousis,George Mertzanos,Dimitrios Babalis,Klea Lamnissou
Hellenic Journal of Cardiology. 2020;
[Pubmed] | [DOI]
131 Menopause symptom management in women with dyslipidemias: An EMAS clinical guide
Panagiotis Anagnostis,Johannes Bitzer,Antonio Cano,Iuliana Ceausu,Peter Chedraui,Fatih Durmusoglu,Risto Erkkola,Dimitrios G. Goulis,Angelica Lindén Hirschberg,Ludwig Kiesel,Patrice Lopes,Amos Pines,Mick van Trotsenburg,Irene Lambrinoudaki,Margaret Rees
Maturitas. 2020; 135: 82
[Pubmed] | [DOI]
132 Model selection for metabolomics: predicting diagnosis of coronary artery disease using automated machine learning
Alena Orlenko,Daniel Kofink,Leo-Pekka Lyytikäinen,Kjell Nikus,Pashupati Mishra,Pekka Kuukasjärvi,Pekka J Karhunen,Mika Kähönen,Jari O Laurikka,Terho Lehtimäki,Folkert W Asselbergs,Jason H Moore,Janet Kelso.
Bioinformatics. 2020; 36(6): 1772
[Pubmed] | [DOI]
133 Influenza vaccine and cardiac protection: a study from a tertiary care center
Umayya Musharrafieh,Jad Dergham,Carla Daou,Hani Tamim,Rana Houry,Abdul Rahman Bizri
Human Vaccines & Immunotherapeutics. 2020; 16(4): 846
[Pubmed] | [DOI]
134 Progressive Muscle Relaxation (PMR) Enhances Oxygen Saturation in Patients of Coronary Heart Disease
A Cahyati,L Herliana,S Februanti
Journal of Physics: Conference Series. 2020; 1477: 062018
[Pubmed] | [DOI]
135 The Role of Gender in the Importance of Risk Factors for Coronary Artery Disease
Farshid Gheisari,Melika Emami,Hadi Raeisi Shahraki,Saeid Samipour,Parastoo Nematollahi
Cardiology Research and Practice. 2020; 2020: 1
[Pubmed] | [DOI]
136 Is the History of Erectile Dysfunction a Reliable Risk Factor for New Onset Acute Myocardial Infarction? A Systematic Review and Meta-Analysis
Ahmed Adam,Jared McDowall,Sunday Joseph Aigbodion,Callistus Enyuma,Sean Buchanan,Ahmed Vachiat,Judy Sheahan,Abdullah Ebrahim Laher
Current Urology. 2020; 14(3): 122
[Pubmed] | [DOI]
137 Scientist-led Exercise Testing Is Safe With Diagnostic Interpretation Equivalent to a Cardiologist
Mark Whitman,Cliantha Padayachee,Prue Tilley,Casey Sear,Shelley Rosanoff,Hadeir El Shinawi,Christiana Manolis,Carly Jenkins,Prasad Challa
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 2020; 19(1): 14
[Pubmed] | [DOI]
138 Relationship of periodontitis and edentulism to angiographically diagnosed coronary artery disease: A cross-sectional study
Mehtap Bilgin Çetin,Canan Önder,Kaan Orhan,Deniz Kumbasar,Muhittin Abdulkadir Serdar,Elif Ünsal
Journal of Periodontal Research. 2020; 55(6): 895
[Pubmed] | [DOI]
139 Contribution of CYP24A1 variants in coronary heart disease among the Chinese population
Peng Qian,Xuanchao Cao,Xianjing Xu,Mingqin Duan,Qian Zhang,Gairong Huang
Lipids in Health and Disease. 2020; 19(1)
[Pubmed] | [DOI]
140 Eating behavior affects cardio-metabolic risk in high school teenagers in a developing country
Rita Suhadi,Phebe Hendra,Dita Maria Virginia,Christianus Heru Setiawan
Medical Journal of Indonesia. 2020; 29(1): 71
[Pubmed] | [DOI]
141 Awareness of the Risk Factors for Heart Attack Among the General Public in Pahang, Malaysia: A Cross-Sectional Study
Abdullah Abdulmajid Abdo Ahmed,Abdulkareem Mohammed AL-Shami,Shazia Jamshed,Mohammed Zawiah,Mohamed Hassan Elnaem,Mohamed Izham Mohamed Ibrahim
Risk Management and Healthcare Policy. 2020; Volume 13: 3089
[Pubmed] | [DOI]
142 Antiplatelet Ilaç Kullaniminin Mesane Kanseri Tanisi Üzerindeki Etkileri: Kolaylastirici mi, Zorlastirici mi?
Haci Ibrahim CIMEN,Deniz GUL
Yeni Üroloji Dergisi. 2020; 15(2): 3
[Pubmed] | [DOI]
143 Association between Coronary Artery Disease and rs10757278 and rs1333049 Polymorphisms in 9p21 Locus in Iran
Farbod Yaghoubi Hariri,Iman Salahshourifar,Shohreh Zare Karizi
Reports of Biochemistry and Molecular Biology. 2020; 9(1): 58
[Pubmed] | [DOI]
144 Evaluation of Psychological Stress Parameters in Coronary Patients by Three Different Questionnaires as Pre-Requisite for Comprehensive Rehabilitation
Ana Maria Pah,Nicoleta Florina Buleu,Anca Tudor,Ruxandra Christodorescu,Dana Velimirovici,Stela Iurciuc,Maria Rada,Gheorghe Stoichescu-Hogea,Marius Badalica-Petrescu,Doina Georgescu,Dorina Nutiu,Mircea Iurciuc,Simona Dragan
Brain Sciences. 2020; 10(5): 316
[Pubmed] | [DOI]
145 Spatial Co-Clustering of Cardiovascular Diseases and Select Risk Factors among Adults in South Africa
Timotheus B. Darikwa,Samuel O. Manda
International Journal of Environmental Research and Public Health. 2020; 17(10): 3583
[Pubmed] | [DOI]
146 Modifying Stressors Using Betty Neuman System Modeling in Coronary Artery Bypass Graft: a Randomized Clinical Trial
Elham Akhlaghi,Sima Babaei,Shahla Abolhassani
Journal of Caring Sciences. 2020; 9(1): 13
[Pubmed] | [DOI]
147 Predictors of cardiac self-efficacy among patients diagnosed with coronary artery disease in tertiary hospitals in Nepal
Rabina Shrestha,Lal Rawal,Rashmita Bajracharya,Anup Ghimire
Journal of Public Health Research. 2020; 9(4)
[Pubmed] | [DOI]
148 Metabolic changes after bariatric surgical procedures
Mohammed Ahmed,Saad Hummady,Falih ALgazgoos
Iraqi National Journal of Medicine. 2020; 2(1): 14
[Pubmed] | [DOI]
149 Modifiable and Non-modifiable Risk Factors in Myocardial Infarction in the Iranian Population
Mina Abolfazli, Mahshid Akbari, Mohammad Abbasinia, Mina Gaeeni, Bahman Aghaie
Journal of Vessels and Circulation. 2020; 1(4): 21
[Pubmed] | [DOI]
150 Atherosklerosis and dementia
Anna Zatloukalová,Martin Roubec,David Školoudík,Petr Ambroz,Ondrej Machaczka,Jana Janoutová,Vladimír Janout
Profese online. 2020; 13(1): 17
[Pubmed] | [DOI]
151 Supplementation with psyllium seed husk reduces myocardial damage in a rat model of ischemia/reperfusion
Sun Ha Lim,Jongwon Lee
Nutrition Research and Practice. 2019; 13(3): 205
[Pubmed] | [DOI]
152 Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
Do Seon Song,U Im Chang,Sung-Goo Kang,Sang-Wook Song,Jin Mo Yang
Gut and Liver. 2019; 13(6): 658
[Pubmed] | [DOI]
153 A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Gagan D. Flora,Manasa K. Nayak
Current Pharmaceutical Design. 2019; 25(38): 4063
[Pubmed] | [DOI]
154 THE ASSOCIATION BETWEEN LOW DIASTOLIC BLOOD PRESSURE AND HIGH ATHEROSCLEROTIC VASCULAR BURDEN IN PATIENTS WITH CORONARY ARTERY DISEASE
Kavirayani P. Hemamalini,Bitra Veera Raghavulu,Akula Annapurna,Gadamsetty Rajkumar,Challapalli Narasimha Raju
Journal of Evidence Based Medicine and Healthcare. 2019; 6(14): 1109
[Pubmed] | [DOI]
155 Alterations in the gut microbiome and metabolism with coronary artery disease severity
Honghong Liu,Xi Chen,Xiaomin Hu,Haitao Niu,Ran Tian,Hui Wang,Haiyu Pang,Lingjuan Jiang,Bintao Qiu,Xiuting Chen,Yang Zhang,Yiyangzi Ma,Si Tang,Hanyu Li,Siqin Feng,Shuyang Zhang,Chenhong Zhang
Microbiome. 2019; 7(1)
[Pubmed] | [DOI]
156 Change in Trajectories of Adherence to Lipid-Lowering Drugs Following Non-Fatal Acute Coronary Syndrome or Stroke
Arsène Zongo,Scot Simpson,Jeffrey A. Johnson,Dean T. Eurich
Journal of the American Heart Association. 2019; 8(23)
[Pubmed] | [DOI]
157 Obstructive sleep apnoea in acute coronary syndrome
Winfried Randerath,Maria R. Bonsignore,Simon Herkenrath
European Respiratory Review. 2019; 28(153): 180114
[Pubmed] | [DOI]
158 Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future
Lun Wang,Yang Zhang,Shu-Yang Zhang
Chinese Medical Journal. 2019; 132(24): 2972
[Pubmed] | [DOI]
159 Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?
Narendra S. Choudhary,Ajay Duseja
Journal of Clinical and Experimental Hepatology. 2019; 9(4): 506
[Pubmed] | [DOI]
160 Anthropometrics, diet, and resting energy expenditure in Norwegian adults with achondroplasia
Andrea Madsen,Svein O. Fredwall,Grethe Maanum,Christine Henriksen,Hanne B. Slettahjell
American Journal of Medical Genetics Part A. 2019; 179(9): 1745
[Pubmed] | [DOI]
161 Development of a joint population pharmacokinetic model of ezetimibe and its conjugated metabolite
K. Soulele,V. Karalis
European Journal of Pharmaceutical Sciences. 2019; 128: 18
[Pubmed] | [DOI]
162 APOE hypermethylation is significantly associated with coronary heart disease in males
Huihui Ji,Cong Zhou,Ranran Pan,Liyuan Han,Weihua Chen,Xiaofeng Xu,Yi Huang,Tianyi Huang,Yuhao Zou,Shiwei Duan
Gene. 2019; 689: 84
[Pubmed] | [DOI]
163 Optimal Non-invasive Strategies to Reduce Recurrent Atherosclerotic Cardiovascular Disease Risk
Maeve Jones-O’Connor,Pradeep Natarajan
Current Treatment Options in Cardiovascular Medicine. 2019; 21(8)
[Pubmed] | [DOI]
164 Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention
Hui-Chao Pan,Xian-Hao Wu,Qian-Li Wan,Bao-Hong Liu and,Xu-Sheng Wu
Experimental Biology and Medicine. 2018; 243(12): 970
[Pubmed] | [DOI]
165 Genetic and Environmental Dispositions for Cardiovascular Variability: A Pilot Study
Radmila Karan,Suzana Cvjeticanin,Natasa Kovacevic-Kostic,Dejan Nikolic,Milos Velinovic,Vladimir Milicevic,Biljana Obrenovic-Kircanski
Journal of Clinical Medicine. 2018; 7(9): 232
[Pubmed] | [DOI]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   Introduction
   Summary
    References

 Article Access Statistics
    Viewed26753    
    Printed188    
    Emailed0    
    PDF Downloaded3038    
    Comments [Add]    
    Cited by others 165    

Recommend this journal